Target intelligence / Profile preview

Collapsin response mediator protein 1 (CRMP1)

Target
CRMP1
Molecular classification
Cytosolic phosphoprotein, Enzyme (hydrolase superfamily), Axon guidance molecule, Other (signaling mediator, cytoskeletal regulator)
01

Overview

Collapsin response mediator protein 1 (CRMP1) is a cytosolic phosphoprotein predominantly expressed in the nervous system, where it regulates critical developmental processes including axon guidance, dendritic development, and synaptic maturation by mediating semaphorin and reelin signaling pathways. CRMP1 functions downstream of class 3 semaphorins (e.g., SEMA3A) to remodel the neuronal cytoskeleton through direct interactions with microtubules and actin filaments, facilitating growth cone collapse and neural circuit formation. CRMP1 forms tetramers and interacts with other CRMP family members, and its activity is regulated by phosphorylation through kinases such as Cdk5, GSK-3β, and Fyn, which impacts neuronal migration, plasticity, and possibly cytokinesis. Disruption or mutation of CRMP1 is implicated in neurodevelopmental diseases, cognitive dysfunction, and has a role in certain cancers. Key references for the functions, structure, and disease linkage include several structural biology, neurodevelopmental genetics, and general summaries from genetic databases. There are currently no known drugs or established biomarkers for CRMP1, and direct targeting as a therapeutic is not reported, but it remains a significant node in neural signal transduction and development.

Other names
Dihydropyrimidinase-related protein 1DPYSL1ULIP3DRP-1CRMP-1ULIP-3DRP1Unc-33-like phosphoprotein 3inactive dihydropyrimidinase
02

Biological functions

Neuronal differentiationAxon guidanceSemaphorin signal transductionCytoskeletal remodelingSynapse formation and maturationCell migrationCytokinesis
03

Disease associations

Neurodevelopmental diseaseNeurodegenerative diseaseCancerOther (associated with learning and memory deficits)
04

Safety considerations

Potential effects on neurodevelopment and neural plasticity due to its regulation of cytoskeleton and neuronal migration; deficiency may cause cognitive or neurodevelopmental dysfunction

Beyond the preview

Go deeper on Collapsin response mediator protein 1 (CRMP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collapsin response mediator protein 1 (CRMP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call